Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Ischemic Heart Disease

  Free Subscription


Articles published in J Cardiovasc Pharmacol

Retrieve available abstracts of 33 articles:
HTML format
Text format



Single Articles


    May 2018
  1. VAN TAUNAY JS, Albelda MT, Frias JC, Lipinski MJ, et al
    Biologics and Cardiovascular Disease.
    J Cardiovasc Pharmacol. 2018 May 3. doi: 10.1097/FJC.0000000000000595.
    PubMed     Text format     Abstract available


    April 2018
  2. CHEN S, Zhang S, Luan H, Zeng X, et al
    Correlation Between Extended Leukocyte Differential Count and Coronary Artery Disease.
    J Cardiovasc Pharmacol. 2018 Apr 10. doi: 10.1097/FJC.0000000000000582.
    PubMed     Text format     Abstract available


  3. SALAH EM, Bastacky SI, Jackson EK, Tofovic SP, et al
    Captopril Attenuates Cardiovascular and Renal Disease in a Rat Model of Heart Failure With Preserved Ejection Fraction.
    J Cardiovasc Pharmacol. 2018;71:205-214.
    PubMed     Text format     Abstract available


    March 2018
  4. ABOUZAKI NA, Christopher S, Trankle C, Van Tassell BW, et al
    Inhibiting the inflammatory injury following myocardial ischemia reperfusion with plasma derived alpha-1 anti-trypsin: a post-hoc analysis of the VCU-alpha1RT study.
    J Cardiovasc Pharmacol. 2018 Mar 23. doi: 10.1097/FJC.0000000000000583.
    PubMed     Text format     Abstract available


  5. BISGAIER CL, Oniciu DC, Srivastava RAK
    Comparative Evaluation of Gemcabene and PPAR Ligands in Transcriptional Assays of Peroxisome Proliferator-Activated Receptors: Implication for the Treatment of Hyperlipidemia and Cardiovascular Disease.
    J Cardiovasc Pharmacol. 2018 Mar 21. doi: 10.1097/FJC.0000000000000580.
    PubMed     Text format     Abstract available


  6. MOHAMMAD FIC AM, Al-Allawi NA
    CYP2C19 genotype is an independent predictor of Adverse Cardiovascular Outcome in Iraqi Patients on Clopidogrel Post Percutaneous Coronary Intervention.
    J Cardiovasc Pharmacol. 2018 Mar 12. doi: 10.1097/FJC.0000000000000577.
    PubMed     Text format     Abstract available


    January 2018
  7. SIGURDSSON MI, Waldron NH, Bortsov AV, Smith SB, et al
    Genomics of Cardiovascular Measures of Autonomic Tone.
    J Cardiovasc Pharmacol. 2018 Jan 3. doi: 10.1097/FJC.0000000000000559.
    PubMed     Text format     Abstract available


    December 2017
  8. ABBATE A
    Why the CANTOS Is a Game Changer in Cardiovascular Medicine.
    J Cardiovasc Pharmacol. 2017;70:353-355.
    PubMed     Text format    


    September 2017
  9. JAZMIN FM, Diana RH, Citali SH, Diego LM, et al
    Sex Differences In Vascular Reactivity To Angiotensin Ii During The Evolution Of Myocardial Infarction.
    J Cardiovasc Pharmacol. 2017 Sep 29. doi: 10.1097/FJC.0000000000000542.
    PubMed     Text format     Abstract available


  10. FUSI F, Durante M, Gorelli B, Perrone MG, et al
    MC225, a novel probe for P-glycoprotein PET Imaging at the blood-brain barrier: in vitro cardiovascular safety evaluation.
    J Cardiovasc Pharmacol. 2017 Sep 1. doi: 10.1097/FJC.0000000000000536.
    PubMed     Text format     Abstract available


    August 2017
  11. AUDET N, Dabouz R, Allen BG, Hebert TE, et al
    Nucleoligands- repurposing GPCR ligands to modulate nuclear-localized GPCRs in the cardiovascular system.
    J Cardiovasc Pharmacol. 2017 Aug 29. doi: 10.1097/FJC.0000000000000535.
    PubMed     Text format     Abstract available


  12. LIU ZY, Hu S, Zhong QW, Tian CN, et al
    N-Methyl-D-Aspartate Receptor (NMDAR)-Driven Calcium Influx Potentiates the Adverse Effects of Myocardial Ischemia-Reperfusion Injury Ex Vivo.
    J Cardiovasc Pharmacol. 2017 Aug 4. doi: 10.1097/FJC.0000000000000527.
    PubMed     Text format     Abstract available


    July 2017
  13. KLJUCEVIC N, Milat AM, Grga M, Mudnic I, et al
    White wine consumption influences inflammatory phase of repair following myocardial infarction in rats.
    J Cardiovasc Pharmacol. 2017 Jul 19. doi: 10.1097/FJC.0000000000000519.
    PubMed     Text format     Abstract available


  14. CAO S, Zhou Q, Chen JL, Cui JJ, et al
    Comparison of Intracoronary and Intravenous Ultrasound-targeted Microbubble Destruction-mediated Ang1 Gene Transfection on Left Ventricular Remodeling in Canines With Acute Myocardial Infarction.
    J Cardiovasc Pharmacol. 2017;70:25-33.
    PubMed     Text format     Abstract available


    June 2017
  15. ZHONG Y, Zhong P, He S, Zhang Y, et al
    Trimetazidine Protects Cardiomyocytes Against Hypoxia/Reoxygenation Injury by Promoting AMP-activated Protein Kinase-dependent Autophagic Flux.
    J Cardiovasc Pharmacol. 2017;69:389-397.
    PubMed     Text format     Abstract available


    May 2017
  16. HARISSEH R, Chiari P, Villedieu C, Sueur P, et al
    Cyclophilin D Modulates the Cardiac Mitochondrial Target of Isoflurane, Sevoflurane, and Desflurane.
    J Cardiovasc Pharmacol. 2017;69:326-334.
    PubMed     Text format     Abstract available


  17. VECSERNYES M, Szokol M, Bombicz M, Priksz D, et al
    Alpha-Melanocyte-stimulating Hormone Induces Vasodilation and Exerts Cardioprotection Through the Heme-Oxygenase Pathway in Rat Hearts.
    J Cardiovasc Pharmacol. 2017;69:286-297.
    PubMed     Text format     Abstract available


    April 2017
  18. SERVILLO L, D'Onofrio N, Balestrieri ML
    Ergothioneine Antioxidant Function: From Chemistry to Cardiovascular Therapeutic Potential.
    J Cardiovasc Pharmacol. 2017;69:183-191.
    PubMed     Text format     Abstract available


  19. BEHMENBURG F, Pickert E, Mathes A, Heinen A, et al
    The Cardioprotective Effect of Dexmedetomidine in Rats Is Dose-Dependent and Mediated by BKCa Channels.
    J Cardiovasc Pharmacol. 2017;69:228-235.
    PubMed     Text format     Abstract available


    March 2017
  20. SCHUMACHER SM, Koch WJ
    Non-canonical roles of GRKs in cardiovascular signaling.
    J Cardiovasc Pharmacol. 2017 Mar 17. doi: 10.1097/FJC.0000000000000483.
    PubMed     Text format     Abstract available


  21. MAURO AG, Mezzaroma E, Torrado J, Kundur P, et al
    Reduction of Myocardial Ischemia-Reperfusion Injury by Inhibiting Interleukin-1 Alpha.
    J Cardiovasc Pharmacol. 2017;69:156-160.
    PubMed     Text format     Abstract available


  22. ZHU A, Wei X, Zhang Y, You T, et al
    Propofol Provides Cardiac Protection by Suppressing the Proteasome Degradation of Caveolin-3 in Ischemic/Reperfused Rat Hearts.
    J Cardiovasc Pharmacol. 2017;69:170-177.
    PubMed     Text format     Abstract available


    February 2017
  23. MAURO AG, Mezzaroma E, Marchetti C, Narayan P, et al
    A Preclinical Translational Study Of The Cardioprotective Effects Of Plasma Derived Alpha-1 Anti-Trypsin In Acute Myocardial Infarction.
    J Cardiovasc Pharmacol. 2017 Feb 13. doi: 10.1097/FJC.0000000000000474.
    PubMed     Text format     Abstract available


  24. BORGHI C, Omboni S, Novo S, Vinereanu D, et al
    Early Treatment With Zofenopril And Ramipril In Combination With Acetyl Salicylic Acid In Patients With Left Ventricular Systolic Dysfunction After Acute Myocardial Infarction: Results Of A 5-Year Follow-Up Of Patients Of The Smile-4 Study.
    J Cardiovasc Pharmacol. 2017 Feb 13. doi: 10.1097/FJC.0000000000000473.
    PubMed     Text format     Abstract available


    January 2017
  25. SUN J, Xiang Q, Li C, Wang Z, et al
    Efficacy and safety of novel oral P2Y12 receptor inhibitors in ST-segment elevation myocardial infarction patients undergoing PCI: A systematic review and meta-analysis.
    J Cardiovasc Pharmacol. 2017 Jan 3. doi: 10.1097/FJC.0000000000000459.
    PubMed     Text format     Abstract available


    December 2016
  26. KAPLAN A, Altara R, Eid A, Booz GW, et al
    Update on the Protective Role of Regulatory T Cells in Myocardial Infarction: A Promising Therapy to Repair the Heart.
    J Cardiovasc Pharmacol. 2016;68:401-413.
    PubMed     Text format     Abstract available


    November 2016
  27. ZHANG L, Lu J, Dong W, Tian H, et al
    Meta-Analysis of Comparison of the Newer P2Y12 Inhibitors (Oral Preparation or Intravenous) to Clopidogrel in Patients with Acute Coronary Syndrome.
    J Cardiovasc Pharmacol. 2016.
    PubMed     Text format     Abstract available


    October 2016
  28. BORGHI C, Omboni S, Reggiardo G, Bacchelli S, et al
    Efficacy Of Zofenopril Compared To Placebo And Other Ace-Inhibitors In Patients With Acute Myocardial Infarction And Previous Cardiovascular Risk Factors: A Pooled Individual Data Analysis Of Four Randomized, Double-Blind, Controlled, Prospective Stud
    J Cardiovasc Pharmacol. 2016.
    PubMed     Text format     Abstract available


  29. SEPARHAM A, Ghaffari S, Najafi H, Ghaffari R, et al
    The Impact of Allopurinol on Patients With Acute ST Elevation Myocardial Infarction Undergoing Thrombolytic Therapy.
    J Cardiovasc Pharmacol. 2016;68:265-268.
    PubMed     Text format     Abstract available


    September 2016
  30. WANG C, Li Y, Yang X, Bi S, et al
    Tetramethylpyrazine and astragaloside IV synergistically ameliorate left ventricular remodeling and preserve cardiac function in a rat myocardial infarction model.
    J Cardiovasc Pharmacol. 2016.
    PubMed     Text format     Abstract available


    July 2016
  31. MA F, Li T, Zhang H, Wu G, et al
    MiR-30s Family inhibit the Proliferation and Apoptosis in Human Coronary Artery Endothelial Cells through Targeting the 3'UTR Region of ITGA4 and PLCG1.
    J Cardiovasc Pharmacol. 2016.
    PubMed     Text format     Abstract available


    June 2016
  32. YANG Q, Wang HC, Liu Y, Gao C, et al
    Resveratrol cardioprotection against myocardial ischemia/reperfusion injury involves upregulation of adiponectin levels and multimerization in type 2 diabetic mice.
    J Cardiovasc Pharmacol. 2016.
    PubMed     Text format     Abstract available


    May 2016
  33. CASCON-PEREZ JD, Abellan-Huerta J, Giner-Caro JA, Dau-Villareal DF, et al
    Effectiveness and safety of bivalirudin during percutaneous coronary intervention in acute coronary syndrome in the real world. CARTAGOMAX study.
    J Cardiovasc Pharmacol. 2016.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: